Lars Öhman

Filings at 3 companies/Chief executive officer · Kubator Therapeutics AB

All 5 shown

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Kubator Therapeutics AB Chief executive officer
34,320 SEKOption exercise
TradedMay 30, 2024FiledJun 4, 2024
Kubator Therapeutics AB Chief executive officer
34,320 SEKOption exercise
TradedMay 30, 2024FiledJun 4, 2024
Lipigon Pharmaceuticals AB Chair of the board
102,960 SEKOption exercise
TradedDec 14, 2023FiledDec 16, 2023
Lipigon Pharmaceuticals AB Chair of the board
102,960 SEKOption exercise
TradedDec 14, 2023FiledDec 16, 2023
Kubator Therapeutics AB Deputy chief executive officer
109,500 SEKOpen-market buy
TradedJun 22, 2021FiledJun 23, 2021